News

Dive into the latest news, press releases and reports from the Abacus Medicine Group.

Sune Vorre appointed new Chief Information Officer (CIO) of the Abacus Medicine Group

The Abacus Medicine Group has appointed Sune Vorre as its new Group CIO, and member of the chief executive management team.

Abacus Medicine Group upgrades full-year outlook

Based on strong performance and growing demand in core markets the Abacus Medicine Group is upgrading the full-year outlook for 2023.

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain

Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain.

Sustainability Report 2022: The Abacus Medicine Group continued to work with sustainability and ESG within 6 focus programs

A materiality assessment, an official Diversity & Inclusion strategy, and workshops for increased awareness of sustainability and ESG across the company were among the concrete initiatives in the Group’s strategic sustainability efforts.

Annual Report 2022: Profitability focus pays off for the Abacus Medicine Group

Increasing profitability was a declared target for the Group for 2022 and this was successfully achieved. Based on strong performance especially in the parallel distribution business EBITDA grew 58% to a record level of EUR 26.2 million.

Milestone: 1,000,000,000 euros

The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.